Blood Collection for Research Related to Certain Diseases Involving Blood Vessels
Part of paid clinical trials in Bethesda, Maryland.
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Study ID
- NCT00047996
- Status
- Enrolling By Invitation
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 100 Years
- Healthy Volunteers
- Accepted
Study Details
The collection of human specimens from both patients and healthy volunteers is necessary for the development of laboratory assays to further basic and clinical research studies. This protocol defines the purposes for which specimens will be collected and establishes general conditions under which sample collection will be performed.
Key Dates
- Start date
- Nov 4, 2002
- Status verified
- Jun 2026
Study Design
- Enrollment
- 2,000 participants (estimated)
Arms
- Arm: Group1Clinical Center Patients, Healthy Volunteers
Primary Outcome Measure
evaluating the role of nitric oxide, inflammatory mediators, and endothelial function in inflammatory diseases of the vasculature such as sickle cell disease, coronary artery disease, pulmonary vascular or advanced lung disease, malaria, and sep...
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| National Institutes of Health Clinical Center | Bethesda | Maryland | 20892 | - |
| INOVA Fairfax Hosptial | Fairfax | Virginia | 22042 | - |
Find similar trials in Bethesda, MD
By condition
Related Studies
- Blood Sampling for Research Related to Sickle Cell DiseaseRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- Collection of Human Biospecimens for Basic and Clinical Research Into Globin VariantsRecruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland
- ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic DisordersRecruiting · American Thrombosis and Hemostasis Network · Phoenix, Arizona
- Long-term Follow-up of Subjects with Sickle Cell Disease Treated with Ex Vivo Gene TherapyEnrolling By Invitation · Genetix Biotherapeutics Inc. · Birmingham, Alabama